Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study (Q34409710)

2 August 2017

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study (English)

1 reference

2 August 2017

1 reference

Elsayed SS

1

1 reference

2 August 2017

Shiha G

2

1 reference

2 August 2017

Hamid M

3

1 reference

2 August 2017

Farag FM

4

1 reference

2 August 2017

Azzam F

5

1 reference

2 August 2017

Awad M

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

2 August 2017

1 reference

2 August 2017

38

1 reference

2 August 2017

5

1 reference

2 August 2017

770-774

1 reference

The course of patients after variceal hemorrhage.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Precipitation of hepatic encephalopathy by propranolol in cirrhosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Propranolol in chronic liver disease: a controlled trial of its effect and safety over twelve months.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Comparison of three nonsurgical treatments for bleeding esophageal varices

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

The surgeon's role in the management of portal hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Clinical Pharmacokinetics of Propranolol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices—an interim report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383163

Bleeding esophageal varices: treatment by sclerotherapy and liver transplantation

27 October 2018

1 reference

12 December 2020

Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy

1 reference

12 December 2020

A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding

1 reference

12 December 2020

Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy

1 reference

12 December 2020

Variceal sclerosis in schistosomotic patients: a 5-year follow-up study

1 reference

12 December 2020

Long term survival and severe rebleeding after variceal sclerotherapy

1 reference

12 December 2020

Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study

1 reference

12 December 2020

Treatment of esophageal varices

1 reference

12 December 2020

PORTAL HEMODYNAMICS AND LIVER CELL FUNCTION IN HEPATIC SCHISTOSOMIASIS

1 reference

12 December 2020

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration

1 reference

12 December 2020

Propranolol--a medical treatment for portal hypertension?

1 reference

12 December 2020

Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial

1 reference

12 December 2020

Prognostic factors in upper G.I. bleeding

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.38.5.770

1 reference

2 August 2017

1 reference

2 August 2017

1 reference